US Stock MarketDetailed Quotes

ACAD ACADIA Pharmaceuticals

Watchlist
  • 16.310
  • -0.600-3.55%
Trading Dec 19 09:55 ET
2.71BMarket Cap20.91P/E (TTM)

About ACADIA Pharmaceuticals Company

ACADIA Pharmaceuticals, Inc. engages in the development and commercialization of medicines for central nervous system disorders. Its products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. The company was founded by Mark R. Brann on July 16, 1993 and is headquartered in San Diego, CA.

Company Profile

SymbolACAD
Company NameACADIA Pharmaceuticals
Listing DateMay 27, 2004
Issue Price7.00
Founded1993
CEOMs. Catherine Owens Adams
MarketNASDAQ
Employees598
Fiscal Year Ends12-31
Address12830 El Camino Real,Suite 400
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92130-3331
Phone1-858-558-2871
Websitehttp://www.acadia.com

Company Executives

  • Name
  • Position
  • Salary
  • Catherine Owens Adams
  • Director and Chief Executive Officer
  • --
  • James K. Kihara
  • Vice President, Controller and Chief Accounting Officer
  • --
  • Mark C. Schneyer
  • Executive Vice President and Chief Financial Officer
  • 2.59M
  • Jennifer J. Rhodes
  • Executive Vice President, Chief Legal Officer and Secretary
  • --
  • Dr. Elizabeth H.Z. Thompson, PhD
  • Executive Vice President and Head of Research and Development
  • --
  • Dr. Stephen R. Biggar,M.D.,PhD
  • Chairman of the Board
  • 432.75K
  • Dr. Adora Ndu, Pharm.D.
  • Independent Director
  • 377.75K
  • Laura A. Brege
  • Independent Director
  • 392.75K
  • James F. Daly
  • Independent Director
  • --
  • Dr. Edmund P. Harrigan, M.D.
  • Independent Director
  • 387.75K
  • Dr. Elizabeth A. Garofalo, M.D.
  • Independent Director
  • 377.75K
  • Julian C. Baker
  • Independent Director
  • 377.75K
  • Daniel B. Soland
  • Independent Director
  • 387.75K
Heat List
US
Overall
Symbol
Price
% Chg

No Data